Skip to main content
. 2019 Apr 7;25(13):1618–1627. doi: 10.3748/wjg.v25.i13.1618

Table 1.

Univariate analysis of factors associated with argon plasma coagulation treatment failure for hemorrhagic chronic radiation proctitis.

Variable No. of failure/total patients P-value
Distribution of telangiectasias
Distal rectum (within 10 cm from anal verge) 7/31 0.1361
Entire rectum +/− sigmoid (more than 10 cm from anal verge) 7/14
Surface area covered by telangiectasias
Less than 50% 2/19 0.0112
More than 50% 12/26
Presence of fresh blood
No 3/16 0.3201
Yes 11/29
Ulceration
< 1 cm2 6/33 0.0061
> 1 cm2 8/12
Gender
Female 14/40 0.3053
Male 0/5
Hypertensive
No 11/39 0.3563
Yes 3/6
Diabetic
No 11/40 0.1663
Yes 3/5
Abdominal surgery
No 11/33 0.8651
Yes 3/12
Acute radiation injury
No 14/39 0.1563
Yes 0/6
Requiring blood transfusions
No 7/30 0.2101
Yes 7/15
Number of APC
1 11/33 0.8651
≥ 2 3/12
Age, yr
< 60 8/22 0.4572
≥ 60 6/23
BMI at the first treatment of APC, kg/m2
< 21 7/21 0.7632
≥ 21 7/24
Time from the end of radiotherapy to bleeding, mo
< 8 6/17 0.6372
≥ 8 8/28
Time from the end of radiotherapy to the first time of APC, mo
< 14 8/23 0.5862
≥ 14 6/22
1

Data were calculated using continuity correction;

2

Data were calculated using the χ2 test;

3

Data were calculated using the Fisher exact test.

APC: Argon plasma coagulation; CRP: Chronic radiation proctitis; BMI: Body mass index.